-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
January 01, 2020 - Post-diagnosis weight gain and breast
cancer recurrence in women with early stage breast cancer. … Breast Cancer Res
Treat 2006; 99(1):47-57.
11. Rock CL, McEligot AJ, Flatt SW et al. … Eating pathology and obesity in women at
risk for breast cancer recurrence. … Influence of height, weight, and
obesity on breast cancer incidence and recurrence in Auckland, New … Breast Cancer Res Treat 1987; 9(2):145-50.
13.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - Family
caregiver burden: results of a longitudinal
study of breast cancer patients and their
principal … Frequency and cost of chemotherapy-related
serious adverse effects in a population
sample of women with breast … cancer. … Racial and ethnic disparities in breast
cancer stage, treatment, and survival in the
United States. … A
stopping rule for standard chemotherapy for
metastatic breast cancer: lessons from a
survey of Maryland
-
effectivehealthcare.ahrq.gov/products/cancer-quality-indicator-testing/research
May 19, 2010 - Not all common malignancies were well-represented in this study (e.g., breast cancer), and further evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
August 27, 2012 - = +0.84
RTI International Research Triangle Institute
Maximum Acceptable Breast-Cancer Risk … RTI International Research Triangle Institute
Maximum Acceptable Breast-Cancer Risk
Vasomotor Symptoms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colon-cancer-gene-profiling_technical-brief.pdf
December 01, 2012 - cancer and aid in determination of
prognosis in breast cancer.”6 Using GEP tests could improve the … Given the current role of GEP testing in patients with breast cancer, questions formulated in a
report … cancer. … Impact of Gene Expression
Profiling Tests on Breast Cancer Outcomes
The Johns Hopkins University Evidence … A breast cancer prognostic signature
predicts clinical outcomes in multiple tumor
types.
-
effectivehealthcare.ahrq.gov/products?f%5B0%5D=field_product_type%3Aresearch_report&f%5B1%5D=field_product_type%3Asystematic_review&f%5B2%5D=field_product_type%3Atechnical_brief&sort_by=field_product_pub_date
September 20, 2021 - Product Search
Search Effective Health Care website
Submit search
Search Tip: Use double quotes around phrases to rank exact matches higher in the result list.
580 results
Interventions To Decrease Hospital Length of Stay
Technical Brie…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/evidence-examples_white-paper.pdf
April 01, 2014 - Cancer ................................................................................ 8
Summary … Cancer
Strength of evidence factors:
• Additional Domains:
o Dose-response association: There … cancer. … Among women who received radiation
therapy for breast cancer, major coronary events (i.e., myocardial … Risk of
ischemic heart disease in women after
radiotherapy for breast cancer.
-
effectivehealthcare.ahrq.gov/health-topics/cancer?page=1
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_executive.pdf
September 01, 2014 - Breast Cancer
Eight new observational studies that assessed the
association between 25(OH)D and breast … One new observational study that assessed the
association between 25(OH)D and breast cancer-specific … The NHANES III analysis
reported a significant decrease in breast cancer mortality
during 9 years of … Breast Cancer
Only the B-rated WHI trial evaluated breast cancer. … It
reported no significant reduction in breast cancer incidence
or mortality with combined vitamin
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_executive.pdf
September 01, 2014 - Breast Cancer
Eight new observational studies that assessed the
association between 25(OH)D and breast … One new observational study that assessed the
association between 25(OH)D and breast cancer-specific … The NHANES III analysis
reported a significant decrease in breast cancer mortality
during 9 years of … Breast Cancer
Only the B-rated WHI trial evaluated breast cancer. … It
reported no significant reduction in breast cancer incidence
or mortality with combined vitamin
-
effectivehealthcare.ahrq.gov/products/cancer-decision-support-tools/research-protocol
November 12, 2013 - Deleterious BRCA gene mutations (breast cancer)
Lynch syndrome or presence of deleterious mismatch … Recommendations on screening for breast cancer in average-risk women aged 40-74 years. … BRCA in breast cancer: ESMO Clinical Practice Guidelines. … Practice bulletin no. 122: Breast cancer screening.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-quality-indicator-testing_research.pdf
April 01, 2010 - Not all common malignancies were well-represented
in this study (e.g., breast cancer), and further evaluation
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-clinician-level-strategies-draft-tech-brief.pdf
February 01, 2023 - Randomized controlled trial of a breast cancer Survivor Stories intervention
for African American women … Efficacy of a Weight Loss Intervention for African American Breast
Cancer Survivors. … A Multidisciplinary Patient Navigation Program Improves Compliance
With Adjuvant Breast Cancer Therapy … Patient Navigation Improves Subsequent Breast Cancer Screening After a
Noncancerous Result: Evidence … Taking Care of Yourself and Your Risk for Breast Cancer
(CUIDARSE): A Randomized Controlled Trial of
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresect
January 07, 2011 - It may also occur with other common tumors such as breast cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/web-based_dubenske_presenter.pdf
January 01, 2009 - DuBenske_Presentation_REVISED_FINAL
Source:
Eisenberg
Center
Conference
Series
2009,
Translating
Information
Into
Action:
Improving
Quality
of
Care
Through
Interactive
Media,
Effective
Health
Care
Program
Web
site
(http://www.effectivehe…
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-johnson.pdf
August 27, 2012 - Slide 17
Maximum Acceptable Breast-Cancer Risk
Vasomotor Symptoms
Image: Bar chart with 3 sets … Slide 18
Maximum Acceptable Breast-Cancer Risk
Vasomotor Symptoms
Image: Bar chart with 3 sets
-
effectivehealthcare.ahrq.gov/sites/default/files/siminoff_eccs2012.pdf
January 01, 2012 - be
acquired
as
the
result of new activities
or
taking
on
new
roles (e.g., breast … cancer
survivor).
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - • Deleterious BRCA gene mutations (breast cancer)
• Lynch syndrome or presence of deleterious mismatch … Recommendations on screening for breast
cancer in average-risk women aged 40-74 years. … BRCA in breast cancer: ESMO Clinical Practice
Guidelines. … Practice bulletin no. 122: Breast cancer screening.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vitamin-d-calcium_disposition-comments.pdf
September 15, 2014 - adults.
37 Peer Reviewer 3 Methods For the most part yes unclear why for the subset
analysis for breast … cancer for the WHI study was not
included
We have added the post hoc analysis for breast
and colorectal … cancer
and trend for reduced risk for colorectal cancer. … We have added the data and a discussion of the
hip fracture, colorectal cancer, and breast
cancer findings … cancer.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - Implications of
Multigene Panels for Hereditary Breast
Cancer Risk Assessment. … Network (CISNET),
Breast Cancer Surveillance Consortium
(BCSC). … Breast Cancer Screening Strategies. … Implications of
Multigene Panels for Hereditary Breast
Cancer Risk Assessment. … Imaging
Techniques for Treatment Evaluation for
Metastatic Breast Cancer.